Abbott
Profil
AI · ruleWird geladen…
Prozessprofil
Verfahren nach Seite und Jahr
| Jahr | Verfahren | Kläger | Beklagter | Berufungskläger | Berufungsbeklagter | Patentinhaber | Nutzer |
|---|---|---|---|---|---|---|---|
| 2026 | 7 | 5 | 1 | 0 | 1 | 4 | 3 |
| 2025 | 7 | 4 | 0 | 1 | 2 | 5 | 2 |
| 2024 | 17 | 5 | 6 | 3 | 3 | 10 | 7 |
| 2023 | 10 | 6 | 4 | 0 | 0 | 4 | 6 |
| Alle Jahre | 41 | 20 | 11 | 4 | 6 | 23 | 18 |
Ergebnisbilanz
| Klageart | Seite | Verfahren | Stattgegeben | Teilweise | Abgewiesen | Zurückgenommen | Vergleich | Verfahrensseiten |
|---|---|---|---|---|---|---|---|---|
| Verletzung | Antragsteller | 5 | 0 | 0 | 0 | 4 | 1 | 5 VerfahrenUPC_CFI_491/2024, UPC_CFI_424/2023, UPC_CFI_430/2023, UPC_CFI_425/2023, UPC_CFI_402/2023 |
| Verletzung | Gegenseite | 5 | 0 | 0 | 0 | 5 | 0 | 5 VerfahrenUPC_CFI_499/2023, UPC_CFI_230/2023, UPC_CFI_233/2023, UPC_CFI_396/2023, UPC_CFI_395/2023 |
| Nichtigkeit | Antragsteller | 4 | 0 | 0 | 0 | 4 | 0 | |
| Nichtigkeit | Gegenseite | 6 | 3 | 0 | 1 | 2 | 0 | |
| Berufung | Antragsteller | 4 | 2 | 0 | 2 | 0 | 0 | |
| Berufung | Gegenseite | 2 | 0 | 0 | 2 | 0 | 0 |
Ohne Sachentscheidung beendet
8 von 10 abgeschlossenen Verletzungsklagen (80 %) endeten ohne eine mit dem Verfahren verknüpfte Sachentscheidung.
Prozessvertreter
Melden Sie sich an, um die Kanzleien zu sehen, die diese Gruppe vertreten haben.
Streitfälle
EP2713879, EP3831283, EP4344633 Abbott Diabetes Care Inc.; A. Menarini Diagnostics s.r.l; A.Menarini Diagnostics France SAS +11 weitere Sibio Technology Limited; Abbott Diabetes Care Inc.; Shanghai International Holding Corp. GmbH (Europe) +2 weitere 11 3 Appeal · 2 Generic · 2 Infringement · 2 Provisional measures · 1 Counter claim for revocation · 1 Revocation 2024-03-20 2026-08-14
EP2713879 · EP3831283 · EP4344633
Aktenzeichen Art Eingang Entscheidung UPC_CFI_130/2024 Provisional measures 2024-03-20 2024-06-19 UPC_CFI_131/2024 Provisional measures 2024-03-20 2024-06-19 UPC_CFI_231/2024 diese Gruppe Revocation 2024-05-30 2025-07-21 UPC_CoA_382/2024 diese Gruppe Appeal 2024-07-03 2025-02-14 UPC_CoA_388/2024 diese Gruppe Appeal 2024-07-04 2025-03-06 UPC_CFI_491/2024 diese Gruppe Infringement 2024-08-16 2025-01-18 UPC_CFI_230/2025 diese Gruppe Infringement 2025-03-14 UPC_CFI_780/2025 diese Gruppe Generic 2025-08-21 2026-01-13 UPC_CFI_781/2025 diese Gruppe Generic 2025-08-22 UPC-COA-0000884/2025 diese Gruppe Appeal 2025-09-24 2026-08-14 UPC-CFI-0000943/2026 diese Gruppe Counter claim for revocation 2026-03-16 EP3435866, EP3797685 DexCom Inc.; DexCom, Inc. Abbott B.V.; Abbott Diabetes Care Inc.; Abbott Diagnostics GmbH +9 weitere 5 2 Counter claim for revocation · 2 Infringement · 1 Appeal 2023-07-07 2025-01-20
Aktenzeichen Art Eingang Entscheidung UPC_CFI_230/2023 diese Gruppe Infringement 2023-07-07 UPC_CFI_233/2023 diese Gruppe Infringement 2023-07-07 2024-07-31 CC_586829/2023 diese Gruppe Counter claim for revocation 2023-11-13 2025-01-20 CC_586960/2023 diese Gruppe Counter claim for revocation 2023-11-13 2024-03-14 UPC_CoA_569/2024 diese Gruppe Appeal 2024-09-30 EP2393417, EP3960072 Abbott Diabetes Care Inc. Sibio Technology Limited; Shanghai International Holding Corp. GmbH; Shenzhen SiSensing Co., Ltd +3 weitere 4 2 Provisional measures · 1 Appeal · 1 Infringement 2024-03-20 2026-10-08
Aktenzeichen Art Eingang Entscheidung UPC_CFI_133/2024 Provisional measures 2024-03-20 2024-05-27 UPC-CFI-0001086/2026 Provisional measures 2026-03-27 2026-09-07 UPC-COA-0000162/2026 diese Gruppe Appeal 2026-09-22 UPC-CFI-0003601/2026 diese Gruppe Infringement 2026-10-08 EP3831282 DexCom, Inc. Abbott Diabetes Care Inc.; Abbott B.V.; Abbott Diagnostics GmbH +13 weitere 4 1 Appeal · 1 Counter claim for revocation · 1 Generic · 1 Infringement 2023-10-30 2024-12-30
Aktenzeichen Art Eingang Entscheidung UPC_CFI_395/2023 diese Gruppe Infringement 2023-10-30 2024-10-11 CC_14065/2024 diese Gruppe Counter claim for revocation 2024-03-15 UPC_CFI_625/2024 diese Gruppe Generic 2024-10-28 UPC_CoA_840/2024 Patent erschlossen diese Gruppe Appeal 2024-12-30 EP3988471, EP4070727 Abbott Diabetes Care Inc. Dexcom Inc.; Dexcom International Limited; Dexcom France SAS 4 2 Counter claim for revocation · 2 Infringement 2023-11-13 2024-12-23
Aktenzeichen Art Eingang Entscheidung UPC_CFI_424/2023 diese Gruppe Infringement 2023-11-13 2024-10-24 UPC_CFI_425/2023 diese Gruppe Infringement 2023-11-14 2024-11-20 CC_13509/2024 diese Gruppe Counter claim for revocation 2024-03-14 2024-12-23 CC_20188/2024 diese Gruppe Counter claim for revocation 2024-04-15 EP3988471 Abbott Diabetes Care Inc. Sinocare Inc.; A.Menarini Diagnostics s.r.l.; A.Menarini Diagnostics France SAS +10 weitere 3 1 Appeal · 1 Infringement · 1 Provisional measures 2025-06-27 2026-05-18
Aktenzeichen Art Eingang Entscheidung UPC_CFI_587/2025 Provisional measures 2025-06-27 2025-10-22 UPC-COA-0000901/2025 diese Gruppe Appeal 2025-11-06 2026-04-17 UPC-CFI-0001743/2026 diese Gruppe Infringement 2026-05-18 EP4344633 Abbott Diabetes Care Inc. Sinocare Inc.; A.Menarini Diagnostics s.r.l.; A. Menarini Diagnostics s.r.l +11 weitere 3 1 Appeal · 1 Infringement · 1 Provisional measures 2025-07-04 2026-03-30
Aktenzeichen Art Eingang Entscheidung UPC_CFI_624/2025 Provisional measures 2025-07-04 2025-10-17 UPC-COA-0000899/2025 diese Gruppe Appeal 2025-10-31 2026-03-30 UPC-CFI-0001613/2025 diese Gruppe Infringement 2025-11-17 EP3960072 Abbott Diabetes Care Inc. Lotus NL B.V.; Medeco B.V.; Mediq B.V. +5 weitere 2 1 Infringement · 1 Provisional measures 2025-09-02 2026-03-09
Aktenzeichen Art Eingang Entscheidung UPC_CFI_830/2025 Provisional measures 2025-09-02 2026-02-06 UPC-CFI-0000865/2026 diese Gruppe Infringement 2026-03-09 EP2720610 Abbott Diabetes Care Inc. Lotus NL B.V.; Medeco B.V.; Mediq B.V. +5 weitere 2 1 Infringement · 1 Provisional measures 2025-09-26 2026-03-09
Aktenzeichen Art Eingang Entscheidung UPC_CFI_875/2025 Provisional measures 2025-09-26 2026-02-06 UPC-CFI-0000866/2026 diese Gruppe Infringement 2026-03-09 EP3977921 Abbott Diabetes Care Inc. Dexcom Inc.; Dexcom International Limited 2 1 Counter claim for revocation · 1 Infringement 2023-11-21 2024-12-15
Aktenzeichen Art Eingang Entscheidung UPC_CFI_430/2023 diese Gruppe Infringement 2023-11-21 CC_14848/2024 diese Gruppe Counter claim for revocation 2024-03-28 2024-12-15 EP4026488 DexCom, Inc. Abbott Diabetes Care Inc.; Abbott Laboratories 2 1 Counter claim for revocation · 1 Infringement 2024-01-02 2024-11-25
Aktenzeichen Art Eingang Entscheidung UPC_CFI_499/2023 diese Gruppe Infringement 2024-01-02 2024-11-25 CC_33181/2024 diese Gruppe Counter claim for revocation 2024-06-04 2024-11-25 EP4087195 Abbott Diabetes Care Inc. Dexcom Inc. 2 1 Counter claim for revocation · 1 Infringement 2023-11-01 2024-10-11
Aktenzeichen Art Eingang Entscheidung UPC_CFI_402/2023 diese Gruppe Infringement 2023-11-01 2024-10-11 CC_10129/2024 diese Gruppe Counter claim for revocation 2024-02-26 2024-10-11 EP4111949 DexCom Inc. Abbott Laboratories 2 1 Counter claim for revocation · 1 Infringement 2023-10-30 2024-10-10
Aktenzeichen Art Eingang Entscheidung UPC_CFI_396/2023 diese Gruppe Infringement 2023-10-30 2024-10-10 CC_9804/2024 diese Gruppe Counter claim for revocation 2024-02-23 2024-10-10 EP2387201 Malikie Innovations Limited Abbott B.V.,; Abbott Diabetes Care Inc.; Abbott Diabetes Care Ltd., +3 weitere 1 1 Infringement 2026-08-07 2026-08-07
Aktenzeichen Art Eingang Entscheidung UPC-CFI-0002852/2026 diese Gruppe Infringement 2026-08-07
Alle 41 Verfahren
| Aktenzeichen | Jahr | Seite | Art | Phase |
|---|---|---|---|---|
| UPC-CFI-0003601/2026 | 2026 | Claimant | Infringement | Written Phase |
| UPC-COA-0000162/2026 | 2026 | Respondent | Appeal | Written Phase |
| UPC-CFI-0002852/2026 | 2026 | Defendant | Infringement | Written Phase |
| UPC-CFI-0001743/2026 | 2026 | Claimant | Infringement | Written Phase |
| UPC-CFI-0000943/2026 | 2026 | Claimant | Counter claim for revocation | Written Phase |
| UPC-CFI-0000866/2026 | 2026 | Claimant | Infringement | Written Phase |
| UPC-CFI-0000865/2026 | 2026 | Claimant | Infringement | Written Phase |
| UPC-CFI-0001613/2025 | 2025 | Claimant | Infringement | Written Phase |
| UPC-COA-0000901/2025 | 2025 | Appellant | Appeal | Case Closed |
| UPC-COA-0000899/2025 | 2025 | Respondent | Appeal | Case Closed |
| UPC-COA-0000884/2025 | 2025 | Respondent | Appeal | Case Closed |
| UPC_CFI_781/2025 | 2025 | Claimant | Generic | Written Phase |
| UPC_CFI_780/2025 | 2025 | Claimant | Generic | Case Closed |
| UPC_CFI_230/2025 | 2025 | Claimant | Infringement | Written Phase |
| UPC_CoA_840/2024 | 2024 | Respondent | Appeal | Case Closed |
| UPC_CFI_625/2024 | 2024 | Claimant | Generic | Case Closed |
| UPC_CoA_569/2024 | 2024 | Respondent | Appeal | Case Closed |
| UPC_CFI_491/2024 | 2024 | Claimant | Infringement | Case Closed |
| UPC_CoA_481/2024 | 2024 | Appellant | Appeal | Case Closed |
| UPC_CoA_480/2024 | 2024 | Appellant | Appeal | Case Closed |
| UPC_CoA_388/2024 | 2024 | Respondent | Appeal | Case Closed |
| UPC_CoA_382/2024 | 2024 | Appellant | Appeal | Case Closed |
| CC_33181/2024 | 2024 | Claimant | Counter claim for revocation | Case Closed |
| UPC_CFI_231/2024 | 2024 | Defendant | Revocation | Case Closed |
| CC_20188/2024 | 2024 | Defendant | Counter claim for revocation | Case Closed |
| CC_14848/2024 | 2024 | Defendant | Counter claim for revocation | Case Closed |
| CC_14065/2024 | 2024 | Claimant | Counter claim for revocation | Case Closed |
| CC_13509/2024 | 2024 | Defendant | Counter claim for revocation | Case Closed |
| CC_10129/2024 | 2024 | Defendant | Counter claim for revocation | Case Closed |
| CC_9804/2024 | 2024 | Claimant | Counter claim for revocation | Case Closed |
| UPC_CFI_499/2023 | 2024 | Defendant | Infringement | Case Closed |
| UPC_CFI_430/2023 | 2023 | Claimant | Infringement | Case Closed |
| UPC_CFI_425/2023 | 2023 | Claimant | Infringement | Case Closed |
| CC_586960/2023 | 2023 | Claimant | Counter claim for revocation | Case Closed |
| CC_586829/2023 | 2023 | Claimant | Counter claim for revocation | Case Closed |
| UPC_CFI_424/2023 | 2023 | Claimant | Infringement | Case Closed |
| UPC_CFI_402/2023 | 2023 | Claimant | Infringement | Case Closed |
| UPC_CFI_395/2023 | 2023 | Defendant | Infringement | Case Closed |
| UPC_CFI_396/2023 | 2023 | Defendant | Infringement | Case Closed |
| UPC_CFI_233/2023 | 2023 | Defendant | Infringement | Case Closed |
| UPC_CFI_230/2023 | 2023 | Defendant | Infringement | Case Closed |
Regelbasiert aggregierte Branchen
Wird geladen…